Do you sell tickets for an event, performance or venue?
Find out more about Eventfinda Ticketing.

You missed this – Subscribe & Avoid FOMO!
Future of Macular Degeneration Research & Treatments

When:

Sat 21 Apr 2012, 10:00am–11:30am

Where: Waipuna Hotel & Conference Centre, 58 Waipuna Rd, Mt Wellington, Auckland

Restrictions: All Ages

Ticket Information:

  • Admission: Free

Website:

Macular Degeneration New Zealand (MDNZ) is hosting a free seminar to share information on new advances in treatment and management of age-related macular degeneration (AMD). The seminar is the first in a series that MDNZ will undertake nationally, and is designed to give the audience an update on research and treatment, with time for questions and answers from the floor.

As a disease affecting so many, there is always keen interest about advances in prevention and treatment from both the macular degeneration community and the eye health community. For those that can access it, we live in an information rich age, but filtering what is meaningful and relevant can be challenging. This seminar aims to provide easily understood, up-to-date information to those with an interest in AMD.

AMD is a global challenge and the leading cause of blindness in the developed world. Worldwide it is estimated approximately 30 million people live with AMD. With increasing numbers of people at risk and predictions that as the developing world ages, the prevalence of AMD will dramatically increase in industrialised counties, there is considerable on-going research both in New Zealand and worldwide. AMD research is diverse and involves many areas including prevention, treatment, nutrition, and ways to better utilise the vision a person has.

At the meeting MDNZ will also launch the AMD Alliance International ‘Increasing Understanding of Wet Age-Related Macular Degeneration as a chronic disease’ report. This report highlights the growing global impact of AMD. The report brings into focus the need for communities to be vocal with policy makers to ensure that all those affected by AMD have the access to early intervention, regular, proactive treatment and integrated care, and that research is on-going for improved options.

In New Zealand 1 in 7 people over 50 years old is affected by AMD. There are approximately 25,000 affected with the severe form of wet AMD, with up to 800 new cases per year. In-line with international predictions the prevalence of visual impairment from AMD will almost double over the next 20 years. New Zealand is one of the few countries in the developed world without a national plan or budget to prevent vision loss. This report will help give a voice to the thousands of New Zealanders affected by AMD. People living with wet AMD need and deserve to be heard by policy makers.

info@mdnz.co.nz or phone 021 0311 662

Held in The Cole Theatre, Waipuna Lodge.

Restaurants to book near Future of Macular Degeneration Research & Treatments